AKT1 and prostate cancer: SIRPB1 is a potential oncogene capable of activating Akt signaling to stimulate prostate cancer proliferation (Song et al., 2020), and the SIRPB1 gene confers susceptibility to Crohn’s disease (Tang et al., 2023).